3-D BIOMIMETIC SCAFFOLDS FOR BONE TISSUE ENGINEERING
Project Number5R01DE013380-03
Contact PI/Project LeaderKOHN, DAVID H.
Awardee OrganizationUNIVERSITY OF MICHIGAN AT ANN ARBOR
Description
Abstract Text
DESCRIPTION (Adapted from the Investigator's Abstract): Reconstruction of
skeletal defects represents a major clinical challenge with over 1 million
surgical procedures performed each year. New strategies of regenerating bone
are needed because of limitations with existing techniques. One new strategy is
to create a composite graft in which autologous cells are seeded onto a porous,
degradable scaffold. The scaffold supports the cells, structurally and
biologically, allowing them to grow and secrete new extracellular matrix.
Optimally tissue growth occurs concurrent with scaffold degradation. The degree
of new bone formation is, however, material dependent and not predictable. We
therefore seek to establish material chemistry parameters that could optimize
bone cell function. In pursuit of this goal, we have developed: (1) in vitro
culture methods in which human bone marrow stromal cells (BMSCs) are expanded;
(2) polymer processing techniques to reproducibly fabricate highly porous 3D
poly(lactic-co-glycolic) scaffolds, which have been successfully used to
engineer a number of tissues including bone; (3) materials science design
strategies which enable us to biomimetically modify both the internal
microenvironment of a scaffold and the scaffold surface; and (4) a critical
size cranial defect model in an immunocompromised mouse which has shown that
the human BMSCs are capable of forming new bone in an animal model. The global
hypothesis of the proposed research is that the extracellular microenvironment
provided by the scaffold modulates the ability of human BMSCs to differentiate
toward an osteoblast phenotype, and therefore controls biomineralization and
structural integrity of regenerated bone. Results from our and other
laboratories support this hypothesis, which is tested by synthesizing a series
of model biomimetic materials. First, we synthesize environmentally responsive
or "smart" scaffolds that buffer the microenvironment upon scaffold
degradation. Second, we synthesize scaffolds with a surface that
self-mineralizes into a biological apatite. Third, we use functionally-graded
scaffolds in which mineralization is spatially controlled. The rationale for
each of these 3 biomimetic strategies lies in the way nature has designed the
skeleton. The skeletal system is able to perform its functions using a minimum
amount of mass because biology has utilized design approaches, which include
the ability to adapt to environmental cues (i.e. "smartness"), a hierarchical
organization consisting of elegant mineral synthesis, and an organization that
is optimized for physiological function by having gradients in composition and
structure. In the proposed studies, we aim to exploit aspects of each of these
3 biomimetic strategies in an effort to create biomaterials that will modulate
biological response in a controlled manner.
National Institute of Dental and Craniofacial Research
CFDA Code
121
DUNS Number
073133571
UEI
GNJ7BBP73WE9
Project Start Date
01-April-2001
Project End Date
31-March-2006
Budget Start Date
01-April-2003
Budget End Date
31-March-2004
Project Funding Information for 2003
Total Funding
$210,645
Direct Costs
$139,500
Indirect Costs
$71,145
Year
Funding IC
FY Total Cost by IC
2003
National Institute of Dental and Craniofacial Research
$210,645
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01DE013380-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01DE013380-03
Patents
No Patents information available for 5R01DE013380-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01DE013380-03
Clinical Studies
No Clinical Studies information available for 5R01DE013380-03
News and More
Related News Releases
No news release information available for 5R01DE013380-03
History
No Historical information available for 5R01DE013380-03
Similar Projects
No Similar Projects information available for 5R01DE013380-03